Background: Increasing evidence suggests that glucocorticoids might play a role in blood pressure (BP) control. These reports show that cortisol (F) can increase the BP acting on the mineralocorticoid receptor in kidney, brain, heart, and blood vessel. The aim of this study was to evaluate the effects of F in the renal salt and water reabsorption in essential hypertensive patients (EH).
I
ncreasing evidence suggests that glucocorticoids might play an important role in blood pressure (BP) control inducing hypertension in 70% of patients with Cushing's syndrome 1 and in 20% of patients under corticoid treatment. 2 Moreover, several in vitro and in vivo studies have demonstrated that cortisol (F) activates the mineralocorticoid receptor (MR). [3] [4] [5] [6] This fact is particularly relevant in human physiology, as the concentrations of F are nearly 1000 to 2000 times higher than those of aldosterone. However, the MR is normally protected from the F action through the 11␤-hydroxysteroid dehydrogenase (11␤HSD2) action. This enzyme is expressed in mineralocorticoid target tissues and it is crucial in the kidney where it inactivates F by converting it to cortisone (E), impairing the activation of MR by cortisol. 7, 8 At present, it is known that when 11␤HSD2 activity is impaired the F interacts with the MR, triggering both the sodium and water reabsorption and secondarily increasing the BP. 7, 9 However, it is also known that F can increase the BP by actions on brain, heart, and blood vessel. 10 The most common hypercortisolism states are those that are secondary to Cushing's syndrome. However, high F levels have also been described in patients with the glucocorticoid resistance syndrome, which is a rare disease characterized by a low sensitivity of target tissue to F, thus increasing adrenocorticotrophic hormone (ACTH) levels that promote the F production in the adrenal glands. 11 Molecular alterations associated to glucocorticoid resistance correspond to mutations at the GR gene, especially in exons codifying for the ligand-binding domain. 12, 13 Genetic studies have documented that mutations and polymorphisms at the GR gene might be associated to different metabolic syndromes such as glucocorticoid resistance, glucocorticoid sensitivity, obesity, as well as essential hypertension. 14 The aim of this work was to perform a cross-sectional study to evaluate the effects of F in the renal salt and water reabsorption. Our methodology consisted in the analysis of urinary free cortisol (UFF) excretion, plasma renin activity (PRA), serum aldosterone (SA), and urinary Na/K ratio. In patients with high UFF excretion we performed a dexamethasone suppression test to rule out Cushing's syndrome. We also calculated the serum F/E ratio to estimate the 11␤HSD2 activity in these patients. In addition, we performed binding studies with 3 H-dexamethasone and genetic studies of the glucocorticoid receptor.
Methods

Patients
The patients included in this study were recruited from a governmental outpatient primary care center in Santiago, Chile. We considered as hypertensives those with diastolic BP Ͼ90 mm Hg and systolic BP Ͼ140 mm Hg on at least two occasions on different days. We included only patients with a recent diagnosis of hypertension not taking antihypertensive drugs, which could affect the renin angiotensin system such as ␤-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptors blockers, diuretics, spironolactone and aspirin, or corticosteroid therapy. Weight and height were measured at the time of admission and patients with a body mass index (BMI) Ͼ40 were excluded. All patients had a clinical examination and serum determinations of creatinine, calcium, urea, glucose, and hepatic profile to exclude renal disease, diabetes mellitus, hepatic failure, and hypercalcemia. Using these criteria, we selected 364 essential hypertensive (EH) patients. A group of 102 normotensive subjects of similar age, gender, and BMI was included as controls ( Table 1) . The normotensive subjects were selected from the same primary care center, according to the criteria in which they had a diastolic BP less than 85 mm Hg and a systolic BP less than 140 mm Hg determined at least on two occasions. The normotensives had no family history of hypertension, at least in first degree relatives. The aim of our study was explained to all the subjects who gave their informed consent, according to the guidelines of the Declaration of Helsinki and the study protocol was approved by the Patients were admitted in the metabolic ward between 9 and 10 AM after a 12-h fasting period. All subjects consumed a normal diet with no attempt to control the sodium intake. Upon admission, a catheter was placed in an antecubital vein after resting in the sitting position at least 15 min. Free-flowing blood was withdrawn to measure SA, PRA, serum F and E, ACTH, sodium, and potassium. DNA samples were isolated from the same blood. All patients received instructions on how to collect 24-h urine. Total 24-h urine volumes were measured, and 50-mL aliquots were stored to determine UFF and creatinine (Cr), as well as urinary sodium (Na ϩ ur), potassium excretion (K ϩ ur), and its ratio (Na/K) ( Table 2) . Patients with primary aldosteronism were excluded by determination of SA/PRA ratio Ͼ25 and a positive fludrocortisone suppression test. 
Biochemical Determinations
Serum aldosterone was determined with a commercial RIA kit (Diagnostic Products Corp., Los Angeles, CA) as previously described. 1 The interassay and intra-assay coefficients of variation of SA measurements were 7.1% and 5.1%, respectively. The PRA was measured by a technique developed. 9 The interassay and intra-assay coefficients of variation of PRA measurements were 8.2% and 6.1%, respectively. The ACTH was determined with a chemiluminiscent immunometric assay (Diagnostic Products Corp.). The UFF was determined by radioimmunoassay with a technique developed in our laboratory 15 using a very specific anti-F antibody (cross-reactivity to E Ͻ0.001%). The interassay and intra-assay coefficients of variation of F measurements were 7.7% and 5.6%, respectively. Creatinine was measured by the Jaffe technique. We normalized UFF by Cr (UFF/Cr) in hypertensive patients and normotensive subjects and no significant differences were found between men and women. The upper limit of UFF/Cr was calculated from normotensives (UFF/Cr mean Ϯ 2 SD) and was set at 51.6 g/g; this value is similar to those previously reported by our group. 15 Serum F and E were determined by radioimmunoassay and the F/E ratio was calculated as described in our previous studies.
9,16
Dexamethasone Suppression Test and Diagnosis of Cushing s Syndrome
The dexamethasone suppression test (DST) was performed in patients with a UFF/Cr ratio above the upper limit. To test the responsiveness of the hypothalamuspituitary-adrenal (HPA) axis, 1 mg of dexamethasone (Dx) was given orally at midnight. The next morning blood was drawn for serum determination of F. Serum values of F Ͻ1.8 g/dL were considered suppressed. In addition, all patients underwent physical examination to confirm/discard the existence of Cushing's features.
Isolation of Lymphocytes and [ 3 H]-Dx Binding Assay
Lymphocytes were isolated from 13 EH patients with the highest UFF/Cr ratio and 5 healthy normotensive volunteers. Binding assays were done during the same month to prevent seasonal variation in receptor binding. Lymphocytes were isolated from fresh blood samples with FicollPaque Plus (Amersham Biosciences, NJ) according to the manufacturer'd instructions. Cell pellets were washed twice and resuspended with a saline buffer. A volume of 150 L was used for lymphocytes counting with a Hema- 
Polymerase Chain Reaction Amplification of Exons 5 to 9 and Genetic Analysis of the GR Gene
To perform analysis of ligand-binding domain coding exons, we designed primers to amplify exons 5, 6, 7, 8 and 9␣ of the GR gene (Table 3 , and ϳ100 ng of purified genomic DNA. Each fragment was amplified using the following program: 3 min at 94°C followed by 30 identical cycles of 1 min at 94°C, 1 min at 53°C, and 1 min at 72°C, and a final extension of 10 min at 72°C. The PCR products were analyzed by electrophoresis in a 1% agarose gel, 30 min at 100 V. Subsequently, each product was purified with the commercial kit Quiaquick Gel Extraction (QIAGEN Inc., CA) and sequenced in an ABI prism-377 Genetic Analyzer (Applied Biosystem). Nucleotide sequence of every patient with high UFF and high K d was compared with the coding regions of the NR3C1 gene in chromosome 5 (GI: 37675286) in BLAST (http://www.ncbi.nlm.nih.gov/blast/) and ClustalIW (http://www.ebi.ac.uk/clustalw/). The sequence of the GR gene was also analyzed with the software TROLL (Tandem Repeat Occurrence Locator, http:// bioinfo.ucb.br/troll.html) to detect regions with more than 12 repetitions of di-, tri-O-tetranucleotides.
Statistics
Clinical data are expressed in median (minimum-maximum) and biochemical data are represented as median (25th to 75th percentile). Correlation analyses were performed to evaluate the relationship between variables. Before parametric analyses, we checked assumptions of normality of raw data using the Kolgomorov-Smirnov test. Raw data that showed significant deviations from normality was transformed to log 10 . To compare frequencies observed versus expected in different analysis, we performed a contingent table using the 2 test. We performed a Mann-Whitney test to compare clinical and biochemical parameters in different EH groups. All statistical analyses were conducted using Statistica 6.1 software (Statsoft Inc., Tulsa, OK). Levels of P Ͻ .05 were considered significant.
Results
In EH the UFF/Cr and F/E values were higher than in normotensives, whereas the SA and PRA levels were similar ( Table 1 ). The upper limit value for UFF/Cr was set at 51.6 g/g. According to this value we found high UFF/Cr levels in 123 of 364 (33.7%) EH patients and 5 of 102 (4.9%) normotensive subjects. The EH with high UFF/Cr showed lower PRA levels (1.5 ng/mL/h [0.9 to 2.5 ng/mL/h] v 2.0 ng/mL/h [1.1 to 3.0 ng/mL/h, P ϭ .012; Fig. 1A ), SA levels (7.1 ng/dL [4.1 to 10.5 ng/dL] v 7.9 ng/dL [5.2 to 11.0 ng/dL], P ϭ .045; Fig. 1B) , and Na/K ratios (3.6 [2.8 to 5.8] v 4.0 [3.1 to 6.6], P Յ .05) than those with normal UFF/Cr. We found a slight negative relationship between UFF/Cr and PRA (r ϭ Ϫ0.117, P ϭ .031; Fig. 2A ), SA (r ϭ Ϫ0.096, P ϭ .058; Fig. 2B ) and Na/K ratios (r ϭ 0.176, P ϭ .059).
In EH patients with high and normal UFF/Cr we did not find significant differences in the serum F/E ratio, urinary sodium, and ACTH levels ( Table 2) . We also did not find significant correlations between UFF/Cr and F/E ratio (r ϭ 0.032, P ϭ .582), BMI values (r ϭ Ϫ0.053, P ϭ .320), or urinary sodium values (r ϭ Ϫ0.059, P ϭ .301). We found a marginally significant proportion of EH patients with high UFF/Cr (42%) which were in more severe stages of hypertension (stages II and III) when compared with the EH patients with normal UFF/Cr (32%) [ 2 (1 df) ϭ 3.82; P ϭ .051]. However, we did not find any association between UFF/Cr and systolic BP (P ϭ .349) or diastolic BP (P ϭ .895). Forty EH patients with the highest UFF/Cr values underwent DST. We observed that all of them suppressed their serum F value in the absence of physical signs of Cushing's syndrome. We also invited the 13 EH patients with the highest UFF/Cr values and 5 sex-and agematched normotensive subjects to continue the study, performing binding assays in circulating lymphocytes using Dx as ligand of the GR. The K d normal range was 7.9 Ϯ 2.6 nmol/L, and 4 EH patients showed K d values above the upper limit (33.0, 17.4, 14.4, 13.7 nmol/L), which are presented in Table 4 . Correlation coefficient values in Scatchard plots were between 0.900 and 0.999.
In the four patients with high K d values, we did not find any mutation in the DNA or ligand-binding domain coding exons (exons 5 to 9) of the GR gene when we compared to the nucleotide sequence published in the GenBank (GI: 37675286), and those obtained from the sequence of two healthy normotensive controls. However, the genetic analysis performed with the TROLL software revealed the presence of a microsatellite region of 17 GT repeats located in the intron 2 IVS2ϩ31085 (GT) 17 .
Discussion
The major finding of this study is the identification of a group of EH patients with a subtle elevation of urinary F excretion, which represents around 30% of the hypertensive population studied. The increase of UFF in other hypertensive populations has been previously described. Litchfield et al 18 studied 153 hypertensives and found that 30% of them presented elevation of UFF levels in a sexand salt intake-dependent pattern, whereas Walker et al 19 found that 7 of 20 EH had a long F half-life, reinforcing our own results that F abnormalities occur in one-third of hypertensive patients. On the other hand, Shamim et al 20 reported a study of 60 hypertensives, which presented elevation of urinary F metabolites that was correlated with premature high systolic BP. Moreover, Gómez-Sanchez et al 21 also detected higher levels of UFF in 47 hypertensives compared with 37 normotensives in the absence of significant differences in urinary F metabolites between both groups. The EH patients showed a slight negative relationship between UFF/Cr and PRA or SA levels that could explain only a 10% and 12% of the variation of SA and PRA, respectively. We also found that EH patients with high UFF showing lower PRA, SA, and urinary Na/K levels than EH with normal-low UFF levels. However, only the Na/K ratio was lower in hypertensives than normotensives. According to these data, we suggest that F has a minor mineralocorticoid action and another mechanism could be operating in the F-induced hypertension, because we did not find a correlation between UFF and BP. At present it is known that MR in normal conditions seems to be largely occupied by glucocorticoid, although inactivated, and then a slight increase in the glucocorticoid levels, such as those found in our patients, could have a minor effect in the receptor activation. 22, 23 More important seems to be the changes in the redox state at the MR by inhibition of 11␤HSD2 activity, generation of reactive oxygen species, or intracellular introduction of oxidized glutathione that allow F to activate the MR. 22, 23 In the present study we found higher serum F/E ratios in EH than in normotensives, similar to those previously reported by our group, 9, 16 suggesting that mild changes in the 11␤HSD2 activity occur in the hypertensive population, which could induce the activation of the MR. However, other important mechanisms have been proposed in the F-induced hypertension, such as inhibition of the vasodilator nitric oxide system or increases in vasoconstrictor erythropoietin concentration, which also could be operating in our hypertensive population. 10, 24, 25 The origin of hypercortisoluria in our EH patients was not clearly determined. A subclinical Cushing's syndrome was discarded, because all patients with elevated UFF/Cr suppressed the F levels with DST, considered as the gold standard in the diagnosis of hypercortisolism by Cushing. 26 We also discarded an increase in the UFF secondary to an increase in the body mass, because the BMI did not correlate with UFF, renin activity, or SA (data not shown). An 11␤HSD2 deficiency is also unlikely, because we did not find a correlation between UFF excretion and the F/E ratio, as used in our previous studies to evaluate the 11␤HSD2 activity. 9, 16 The presence of a glucocorticoid resistance was evaluated through lymphocyte-binding assays with labeled Dx and showed that at least 4 of 13 EH patients had an affinity two to four times lower when compared to normotensives. A similar result was found by Mulatero et al 27 using also lymphocytes of 17 EH and 11 normotensives. They demonstrated that the binding of F and Dx was lower in EH, who also had lower PRA. However, against the classic generalized glucocorticoid resistance the DST suppresses the F and in both studies the ACTH levels were in normal range, suggesting that more specific and sensitive tests might be required to diagnose minor form of the disease.
The genetic study of the GR gene did not demonstrate the presence of mutations in the ligand-binding domain codifying exons. In the past decade there have been increasing reports of patients with a clinical and biochemical presentation compatible to glucocorticoid resistance and without mutations in the GR gene, suggesting that other factors might be responsible for the glucocorticoid resistance phenotype. 28 In spite of the failure to detect genetic mutations, we found a microsatellite region of the dinucleotide GT (17 repeats) in the intron 2 of the GR gene, whose role on gene transcription and translation remains to be analyzed. Microsatellite regions have been demon- Abbreviations as in Table 1 . ND ϭ not determined.
strated to be associated to metabolic syndromes. Agarwal et al communicated the existence of a dinucleotide CA repeat in the intron 1 of the 11␤HSD2 gene, which was also studied by our group, demonstrating an association between the length of this microsatellite and hypertension. 16, 29, 30 In summary, we found a population of EH with abnormally high values of UFF, and evidence of a minor mineralocorticoid action not directly related to the BP elevation. These results suggest that an alternative mechanism could be operating in the F-induced hypertension, such as those reported on brain, heart, and blood vessels. The origin of hypercortisoluria was not elucidated; however, a subtle glucocorticoid resistance was found in some cases. 26 
